Exact Mass: 731.5522152

PE(P-16:0/20:0)

C41H82NO7P (731.5828592)

PE(P-16:0/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/20:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(P-16:0/20:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-16:0/20:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of arachidic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(16:0/16:1(9Z))

C40H78NO8P (731.5464757999999)

PC(16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/16:1(9Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

Araliacerebroside

C40H77NO10 (731.5547182)

Araliacerebroside is found in green vegetables. Araliacerebroside is a constituent of the root bark of Aralia elata (Japanese angelica tree). Constituent of the root bark of Aralia elata (Japanese angelica tree). Araliacerebroside is found in green vegetables.

PC(14:0/18:1(11Z))

C40H78NO8P (731.5464757999999)

PC(14:0/18:1(11Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:1(11Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of vaccenic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the vaccenic acid moiety is derived from butter fat and animal fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(14:0/18:1(9Z))

C40H78NO8P (731.5464757999999)

PC(14:0/18:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/18:1(9Z)), in particular, consists of one chain of myristic acid at the C-1 position and one chain of oleic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(14:1(9Z)/18:0)

C40H78NO8P (731.5464757999999)

PC(14:1(9Z)/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:1(9Z)/18:0), in particular, consists of one chain of myristoleic acid at the C-1 position and one chain of stearic acid at the C-2 position. The myristoleic acid moiety is derived from milk fats, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(15:0/P-18:0)

C41H82NO7P (731.5828592)

PC(15:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/P-18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(15:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(15:0/P-18:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(16:1(9Z)/16:0)

C40H78NO8P (731.5464757999999)

PC(16:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:1(9Z)/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:1(9Z)/16:0), in particular, consists of one chain of palmitoleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The palmitoleic acid moiety is derived from animal fats and vegetable oils, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:0/14:1(9Z))

C40H78NO8P (731.5464757999999)

PC(18:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/14:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/14:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/14:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the myristoleic acid moiety is derived from milk fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PC(18:1(11Z)/14:0)

C40H78NO8P (731.5464757999999)

PC(18:1(11Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(11Z)/14:0), in particular, consists of one chain of vaccenic acid at the C-1 position and one chain of myristic acid at the C-2 position. The vaccenic acid moiety is derived from butter fat and animal fat, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PC(18:1(9Z)/14:0)

C40H78NO8P (731.5464757999999)

PC(18:1(9Z)/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:1(9Z)/14:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of myristic acid at the C-2 position. The oleic acid moiety is derived from vegetable oils, especially olive and canola oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC.

PE(15:0/20:1(11Z))

C40H78NO8P (731.5464757999999)

PE(15:0/20:1(11Z)) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/20:1(11Z)), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of eicosenoic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the eicosenoic acid moiety is derived from vegetable oils and cod oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.

PE(18:0/P-18:0)

C41H82NO7P (731.5828592)

PE(18:0/P-18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(18:0/P-18:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE(20:0/P-16:0)

C41H82NO7P (731.5828592)

PE(20:0/P-16:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:0/P-16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.

PE(20:1(11Z)/15:0)

C40H78NO8P (731.5464757999999)

PE(20:1(11Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/15:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(20:1(11Z)/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(20:1(11Z)/15:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The eicosenoic acid moiety is derived from vegetable oils and cod oils, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(16:0/18:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe(16:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/18:1(9Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. PE-NMe(16:0/18:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. (Lipid Library, Lipid MAPS) [HMDB]

PC(P-18:0/15:0)

C41H82NO7P (731.5828592)

PC(P-18:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/15:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/15:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/15:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE(P-18:0/18:0)

C41H82NO7P (731.5828592)

PE(P-18:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(P-18:0/18:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS.Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PE(dm18:0/18:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(dm18:0/18:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of stearic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(14:0/20:1(11Z))

C40H78NO8P (731.5464757999999)

PE-NMe(14:0/20:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/20:1(11Z)), in particular, consists of one tetradecanoyl chain to the C-1 atom, and one 11Z-eicosenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(14:1(9Z)/20:0)

C40H78NO8P (731.5464757999999)

PE-NMe(14:1(9Z)/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:1(9Z)/20:0), in particular, consists of one 9Z-tetradecenoyl chain to the C-1 atom, and one eicosanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(16:0/18:1(11Z))

C40H78NO8P (731.5464757999999)

PE-NMe(16:0/18:1(11Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/18:1(11Z)), in particular, consists of one hexadecanoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(16:1(9Z)/18:0)

C40H78NO8P (731.5464757999999)

PE-NMe(16:1(9Z)/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:1(9Z)/18:0), in particular, consists of one 9Z-hexadecenoyl chain to the C-1 atom, and one octadecanoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe(18:0/16:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe(18:0/16:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/16:1(9Z)), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(11Z)/16:0)

C40H78NO8P (731.5464757999999)

PE-NMe(18:1(11Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(11Z)/16:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(18:1(9Z)/16:0)

C40H78NO8P (731.5464757999999)

PE-NMe(18:1(9Z)/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:1(9Z)/16:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:0/14:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe(20:0/14:1(9Z)) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/14:1(9Z)), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristoleic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe(20:1(11Z)/14:0)

C40H78NO8P (731.5464757999999)

PE-NMe(20:1(11Z)/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:1(11Z)/14:0), in particular, consists of one chain of eicosenoic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(15:0/18:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe2(15:0/18:1(9Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(15:0/18:1(9Z)), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one 9Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(15:0/18:1(11Z))

C40H78NO8P (731.5464757999999)

PE-NMe2(15:0/18:1(11Z)) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions.PE-NMe2(15:0/18:1(11Z)), in particular, consists of one pentadecanoyl chain to the C-1 atom, and one 11Z-octadecenoyl to the C-2 atom. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

PE-NMe2(18:1(11Z)/15:0)

C40H78NO8P (731.5464757999999)

PE-NMe2(18:1(11Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(11Z)/15:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

PE-NMe2(18:1(9Z)/15:0)

C40H78NO8P (731.5464757999999)

PE-NMe2(18:1(9Z)/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(18:1(9Z)/15:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

Phosphatidylcholine 16:0-16:1

C40H78NO8P (731.5464757999999)

Phosphatidylethanolamine 17:0-18:1

C40H78NO8P (731.5464757999999)

Phosphatidylethanolamine alkyl 18:0-18:1

C41H82NO7P (731.5828592)

1-O-(beta-D-glucopyranosyloxy)-(2S,3S,4R,6E)-2[(2R)-2-hydroxyheptadecanoylamino]-8-heptadecene-3,4-diol

C40H77NO10 (731.5547182)

1-O-beta-D-glucopyranosyl-(2S,3S,4R,6E)-[2(R)-2-hydroxypalmitoylamino]-6-octadecene-1,3,4-triol|hippophae cerebroside

C40H77NO10 (731.5547182)

(2R)-N-{(1S,2S,3R,8E)-1-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydroxyheptadec-8-en-1-yl}-2-hydroxyhexadecanamide

C40H77NO10 (731.5547182)

polygalacerebroside

C40H77NO10 (731.5547182)

1-O-beta-D-glucopyranosyl-(2S,3S,4R,9E)-2-[(2R)-2-hydroxyeicosanoylamino]-9-tetradecene-1,3,4-triol

C40H77NO10 (731.5547182)

1,3,4,12-tetrahydroxy-2-(9-hexadecenoylamino)octadecane 1-O-glucopyranoside|bonaroside

C40H77NO10 (731.5547182)

1-16:0-2-18:4-diacylglycerol-trimethylhomoserine

C44H77NO7 (731.5699732)

Phosphatidylethanolamine alkenyl 16:0-20:0

C41H82NO7P (731.5828592)

PC 32:1

C40H78NO8P (731.5464757999999)

Found in mouse lung; TwoDicalId=14; MgfFile=160901_Lung_normal_Neg_03; MgfId=735

1,2-Dierucoyl-sn-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

PC(14:0/18:1)[U]

C40H78NO8P (731.5464757999999)

PC(16:0/16:1)[U]

C40H78NO8P (731.5464757999999)

PC(18:1/14:0)[U]

C40H78NO8P (731.5464757999999)

PE-NMe(16:0/18:1)[U]

C40H78NO8P (731.5464757999999)

PE-NMe(16:0/18:1)

C40H78NO8P (731.5464757999999)

PE-NMe(18:1/16:0)

C40H78NO8P (731.5464757999999)

1-(6-[3]-ladderane-hexanyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerophosphoethanolamine

C43H74NO6P (731.5253473999999)

N-tryptophanyl-35-aminobacteriohopane-32,33,34-triol

C46H73N3O4 (731.5600777999999)

Lecithin

C40H78NO8P (731.5464757999999)

Lecithin

C41H82NO7P (731.5828592)

PE(35:1)

C40H78NO8P (731.5464757999999)

PE(36:0)

C41H82NO7P (731.5828592)

PC(12:0/20:1(11Z))

C40H78NO8P (731.5464757999999)

PC(13:0/19:1(9Z))

C40H78NO8P (731.5464757999999)

PC(15:0/17:1(9Z))

C40H78NO8P (731.5464757999999)

PC(15:1(9Z)/17:0)

C40H78NO8P (731.5464757999999)

PC(17:0/15:1(9Z))

C40H78NO8P (731.5464757999999)

PC(17:1(9Z)/15:0)

C40H78NO8P (731.5464757999999)

PC(19:1(9Z)/13:0)

C40H78NO8P (731.5464757999999)

PC(20:1(11Z)/12:0)

C40H78NO8P (731.5464757999999)

PC(O-16:0/17:1(9Z))

C41H82NO7P (731.5828592)

PC(O-18:0/15:1(9Z))

C41H82NO7P (731.5828592)

PC(P-16:0/17:0)

C41H82NO7P (731.5828592)

PC(P-20:0/13:0)

C41H82NO7P (731.5828592)

PE(13:0/22:1(11Z))

C40H78NO8P (731.5464757999999)

PE(14:1(9Z)/21:0)

C40H78NO8P (731.5464757999999)

PE(15:1(9Z)/20:0)

C40H78NO8P (731.5464757999999)

PE(16:0/19:1(9Z))

C40H78NO8P (731.5464757999999)

PE(16:1(9Z)/19:0)

C40H78NO8P (731.5464757999999)

PE(17:1(9Z)/18:0)

C40H78NO8P (731.5464757999999)

PE(18:0/17:1(9Z))

C40H78NO8P (731.5464757999999)

PE(18:1(9Z)/17:0)

C40H78NO8P (731.5464757999999)

PE(19:0/16:1(9Z))

C40H78NO8P (731.5464757999999)

PE(19:1(9Z)/16:0)

C40H78NO8P (731.5464757999999)

PE(20:0/15:1(9Z))

C40H78NO8P (731.5464757999999)

PE(21:0/14:1(9Z))

C40H78NO8P (731.5464757999999)

PE(22:1(11Z)/13:0)

C40H78NO8P (731.5464757999999)

PE(17:0/18:1(9Z))

C40H78NO8P (731.5464757999999)

PE(O-16:0/20:1(11Z))

C41H82NO7P (731.5828592)

PE(O-18:0/18:1(9Z))

C41H82NO7P (731.5828592)

PE(O-20:0/16:1(9Z))

C41H82NO7P (731.5828592)

PE(P-18:0/18:0)

C41H82NO7P (731.5828592)

PE(P-20:0/16:0)

C41H82NO7P (731.5828592)

Araliacerebroside

C40H77NO10 (731.5547182)

PC O-33:1

C41H82NO7P (731.5828592)

PE-NMe 34:1

C40H78NO8P (731.5464757999999)

PE 35:1

C40H78NO8P (731.5464757999999)

PE O-36:1

C41H82NO7P (731.5828592)

PE dO-38:8

C43H74NO6P (731.5253473999999)

HexCer 34:1;O4

C40H77NO10 (731.5547182)

1-tetradecanoyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (9Z)-octadecenoyl respectively.

1-Palmitoyl-2-palmitoleoylphosphatidylcholine

C40H78NO8P (731.5464757999999)

Phosphatidylethanolamine (1-palmitoyl, 2-lactobacilloyl)

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[10-(2-hexylcyclopropyl)decanoyloxy]propyl] hexadecanoate

C40H78NO8P (731.5464757999999)

PE-NMe2(15:0/18:1(11Z))

C40H78NO8P (731.5464757999999)

2-[[(2S,3R,4E,8Z)-2-[[(Z,9S,10S)-9,10-dihydroxyoctadec-12-enoyl]amino]-3-hydroxyhexadeca-4,8-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C39H76N2O8P+ (731.5339006)

Phosphatidylethanolamine-(O-18:0/18:1(9Z))

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (Z)-octadec-9-enoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] icosanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (Z)-octadec-9-enoate

C40H78NO8P (731.5464757999999)

Ldgcc 34:5

C44H77NO7 (731.5699732)

HexCer 9:1;2O/28:5

C43H73NO8 (731.5335898)

HexCer 9:0;2O/28:6

C43H73NO8 (731.5335898)

NAGly 26:7/19:2

C47H73NO5 (731.5488447999999)

HexCer 13:0;2O/24:6

C43H73NO8 (731.5335898)

HexCer 17:2;2O/20:4

C43H73NO8 (731.5335898)

HexCer 21:2;2O/16:4

C43H73NO8 (731.5335898)

HexCer 13:1;2O/24:5

C43H73NO8 (731.5335898)

HexCer 15:3;2O/22:3

C43H73NO8 (731.5335898)

HexCer 19:1;2O/18:5

C43H73NO8 (731.5335898)

HexCer 17:3;2O/20:3

C43H73NO8 (731.5335898)

HexCer 13:2;2O/24:4

C43H73NO8 (731.5335898)

HexCer 21:3;2O/16:3

C43H73NO8 (731.5335898)

HexCer 15:1;2O/22:5

C43H73NO8 (731.5335898)

HexCer 17:1;2O/20:5

C43H73NO8 (731.5335898)

HexCer 19:2;2O/18:4

C43H73NO8 (731.5335898)

HexCer 11:1;2O/26:5

C43H73NO8 (731.5335898)

HexCer 15:0;2O/22:6

C43H73NO8 (731.5335898)

HexCer 19:3;2O/18:3

C43H73NO8 (731.5335898)

HexCer 15:2;2O/22:4

C43H73NO8 (731.5335898)

HexCer 11:0;2O/26:6

C43H73NO8 (731.5335898)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-hexatriacont-25-enoate

C41H82NO7P (731.5828592)

Lnape 9:0/N-26:1

C40H78NO8P (731.5464757999999)

Lnape 26:1/N-9:0

C40H78NO8P (731.5464757999999)

[3-nonoxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

2-[3-nonanoyloxy-2-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

Lnape 18:1/N-17:0

C40H78NO8P (731.5464757999999)

Lnape 19:1/N-16:0

C40H78NO8P (731.5464757999999)

Lnape 11:0/N-24:1

C40H78NO8P (731.5464757999999)

Lnape 19:0/N-16:1

C40H78NO8P (731.5464757999999)

Lnape 14:1/N-21:0

C40H78NO8P (731.5464757999999)

Lnape 15:1/N-20:0

C40H78NO8P (731.5464757999999)

Lnape 20:0/N-15:1

C40H78NO8P (731.5464757999999)

Lnape 24:1/N-11:0

C40H78NO8P (731.5464757999999)

Lnape 20:1/N-15:0

C40H78NO8P (731.5464757999999)

Lnape 15:0/N-20:1

C40H78NO8P (731.5464757999999)

Lnape 17:0/N-18:1

C40H78NO8P (731.5464757999999)

Lnape 21:0/N-14:1

C40H78NO8P (731.5464757999999)

Lnape 16:1/N-19:0

C40H78NO8P (731.5464757999999)

Lnape 18:0/N-17:1

C40H78NO8P (731.5464757999999)

Lnape 22:1/N-13:0

C40H78NO8P (731.5464757999999)

Lnape 13:0/N-22:1

C40H78NO8P (731.5464757999999)

Lnape 14:0/N-21:1

C40H78NO8P (731.5464757999999)

Lnape 21:1/N-14:0

C40H78NO8P (731.5464757999999)

Lnape 22:0/N-13:1

C40H78NO8P (731.5464757999999)

Lnape 16:0/N-19:1

C40H78NO8P (731.5464757999999)

Lnape 13:1/N-22:0

C40H78NO8P (731.5464757999999)

Lnape 17:1/N-18:0

C40H78NO8P (731.5464757999999)

2-[3-[(Z)-heptadec-9-enoyl]oxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

2-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

2-[2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

2-[2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxy-3-tridecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

2-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-pentadecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

2-[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

2-[2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-3-undecanoyloxypropoxy]-2-[2-(trimethylazaniumyl)ethoxy]acetate

C43H73NO8 (731.5335898)

HexCer 8:0;3O/26:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 9:0;3O/25:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 13:1;3O/21:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 13:0;3O/21:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 12:0;3O/22:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 12:1;3O/22:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 11:0;3O/23:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 10:0;3O/24:1;(2OH)

C40H77NO10 (731.5547182)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] octanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl] (Z)-octacos-17-enoate

C41H82NO7P (731.5828592)

[2-nonanoyloxy-3-[(Z)-tetracos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[3-[(Z)-octacos-17-enoxy]-2-pentanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[2-heptanoyloxy-3-[(Z)-hexacos-15-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

(4E,8E,12E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]icosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)

(E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]hexacos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] tetradecanoate

C41H82NO7P (731.5828592)

(4E,8E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]icosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] decanoate

C41H82NO7P (731.5828592)

(E)-2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxydocos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] pentadecanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] nonadecanoate

C41H82NO7P (731.5828592)

(4E,8E,12E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyoctadeca-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)

(4E,8E,12E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)

(4E,8E)-3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tricosoxypropan-2-yl] (Z)-tridec-9-enoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (Z)-hexadec-9-enoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] hexadecanoate

C41H82NO7P (731.5828592)

(E)-2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyoctadec-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (Z)-pentadec-9-enoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (Z)-nonadec-9-enoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] dodecanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] henicosanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecoxypropan-2-yl] (Z)-tetracos-13-enoate

C41H82NO7P (731.5828592)

(E)-3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]icos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)

3-hydroxy-2-[[(6Z,9Z,12Z,15Z,18Z,21Z)-tetracosa-6,9,12,15,18,21-hexaenoyl]amino]icosane-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-henicos-11-enoate

C41H82NO7P (731.5828592)

(4E,8E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxydocosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] heptadecanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] tricosanoate

C41H82NO7P (731.5828592)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (Z)-heptadec-9-enoate

C41H82NO7P (731.5828592)

(4E,8E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyoctadeca-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-decoxypropan-2-yl] (Z)-hexacos-15-enoate

C41H82NO7P (731.5828592)

2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-3-hydroxydocosane-1-sulfonic acid

C44H77NO5S (731.5522152)

(E)-3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]tetracos-4-ene-1-sulfonic acid

C44H77NO5S (731.5522152)

(4E,8E,12E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxydocosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]tetracosa-4,8,12-triene-1-sulfonic acid

C44H77NO5S (731.5522152)

2-[[(8Z,11Z,14Z,17Z,20Z,23Z)-hexacosa-8,11,14,17,20,23-hexaenoyl]amino]-3-hydroxyoctadecane-1-sulfonic acid

C44H77NO5S (731.5522152)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (Z)-tetradec-9-enoate

C41H82NO7P (731.5828592)

(4E,8E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]tetracosa-4,8-diene-1-sulfonic acid

C44H77NO5S (731.5522152)

[3-[(Z)-docos-13-enoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[3-nonadecoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[3-heptadecoxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[2-[(Z)-docos-13-enoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[2-[(Z)-icos-11-enoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[2-[(Z)-octadec-9-enoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

[3-dodecoxy-2-[(Z)-henicos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C41H82NO7P (731.5828592)

Cer 15:0;2O/16:5;(3OH)(FA 16:5)

C47H73NO5 (731.5488447999999)

4-[2-[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]oxy-3-octanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]oxy-3-dodecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-decanoyloxy-2-[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2,3-bis[[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy]propoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-hexadecanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxy-3-[(Z)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(Z)-hexadec-9-enoyl]oxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

HexCer 22:0;3O/12:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 17:1;3O/17:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 22:1;3O/12:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 19:1;3O/15:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 20:1;3O/14:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 14:1;3O/20:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 15:1;3O/19:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 16:1;3O/18:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 21:0;3O/13:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 14:0;3O/20:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 20:0;3O/14:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 16:0;3O/18:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 19:0;3O/15:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 21:1;3O/13:0;(2OH)

C40H77NO10 (731.5547182)

HexCer 18:0;3O/16:1;(2OH)

C40H77NO10 (731.5547182)

HexCer 15:0;3O/19:1;(2OH)

C40H77NO10 (731.5547182)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-heptadec-9-enoyl]oxypropyl] octadecanoate

C40H78NO8P (731.5464757999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (Z)-icos-11-enoate

C40H78NO8P (731.5464757999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (Z)-docos-13-enoate

C40H78NO8P (731.5464757999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-hexadec-9-enoyl]oxypropyl] nonadecanoate

C40H78NO8P (731.5464757999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] icosanoate

C40H78NO8P (731.5464757999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (Z)-nonadec-9-enoate

C40H78NO8P (731.5464757999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (Z)-tetracos-13-enoate

C40H78NO8P (731.5464757999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] henicosanoate

C40H78NO8P (731.5464757999999)

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(Z)-tridec-9-enoyl]oxypropyl] docosanoate

C40H78NO8P (731.5464757999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] (Z)-henicos-11-enoate

C40H78NO8P (731.5464757999999)

[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[3-dodecanoyloxy-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[3-heptadecanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[3-octadecanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (Z)-hexacos-15-enoate

C40H78NO8P (731.5464757999999)

[3-nonadecanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[2-[(Z)-hexacos-15-enoyl]oxy-3-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[3-decanoyloxy-2-[(Z)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[3-octanoyloxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[2-[(Z)-henicos-11-enoyl]oxy-3-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxy-2-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-2-[(E)-octadec-11-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-[(E)-octadec-13-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-2-[(E)-octadec-7-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-hexadecanoyloxy-3-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-dodecanoyloxy-2-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] (E)-docos-13-enoate

C40H78NO8P (731.5464757999999)

4-[2-[(14E,17E,20E)-tricosa-14,17,20-trienoyl]oxy-3-[(E)-undec-4-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-heptadecanoyloxy-2-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] octadec-17-enoate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] icosanoate

C40H78NO8P (731.5464757999999)

4-[2-[(14E,16E)-docosa-14,16-dienoyl]oxy-3-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-heptadec-9-enoyl]oxypropyl] octadecanoate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-7-enoate

C40H78NO8P (731.5464757999999)

4-[2-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-3-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-icos-11-enoate

C40H78NO8P (731.5464757999999)

4-[3-[(E)-docos-11-enoyl]oxy-2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(E)-icos-11-enoyl]oxy-2-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-octadecanoyloxy-2-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(E)-dec-4-enoyl]oxy-2-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-[(E)-heptadec-9-enoyl]oxy-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(11E,14E)-icosa-11,14-dienoyl]oxy-3-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-2-[(E)-octadec-6-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (E)-docos-13-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-9-enoyl]oxypropyl] nonadecanoate

C40H78NO8P (731.5464757999999)

4-[2-[(E)-nonadec-9-enoyl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-2-[(E)-octadec-11-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(18E,21E)-tetracosa-18,21-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoyl]oxy-2-tetradecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-6-enoate

C40H78NO8P (731.5464757999999)

[(2R)-2-heptadecanoyloxy-3-[(E)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2S)-2-dodecanoyloxy-3-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-2-[(E)-heptadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-pentadec-9-enoyl]oxypropyl] icosanoate

C40H78NO8P (731.5464757999999)

4-[2-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-3-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-11-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-octadec-17-enoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-2-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] (E)-icos-13-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-11-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[(E)-octadec-9-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-hexadec-7-enoyl]oxypropyl] nonadecanoate

C40H78NO8P (731.5464757999999)

4-[2,3-bis[[(11E,14E)-heptadeca-11,14-dienoyl]oxy]propoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-2-[(E)-octadec-4-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-3-dodecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-dodecanoyloxy-2-[(E)-icos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(7E,9E)-nonadeca-7,9-dienoyl]oxy-2-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-hexadecanoyloxy-2-[(9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-2-octadec-17-enoyloxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxy-3-[(E)-heptadec-7-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-2-[(10E,12E)-octadeca-10,12-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxy-2-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (E)-tetracos-15-enoate

C40H78NO8P (731.5464757999999)

4-[3-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-2-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(14E,16E)-docosa-14,16-dienoyl]oxy-2-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-icos-11-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-6-enoate

C40H78NO8P (731.5464757999999)

4-[3-[(10E,13E,16E,19E)-docosa-10,13,16,19-tetraenoyl]oxy-2-dodecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(E)-hexadec-7-enoyl]oxy-2-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] henicosanoate

C40H78NO8P (731.5464757999999)

4-[2-decanoyloxy-3-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-2-[(E)-octadec-9-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-9-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-decanoyloxy-2-[(E)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-7-enoate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-4-enoate

C40H78NO8P (731.5464757999999)

4-[3-[(11E,14E)-icosa-11,14-dienoyl]oxy-2-[(7E,9E)-tetradeca-7,9-dienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(E)-docos-11-enoyl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(E)-icos-11-enoyl]oxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-2-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(9E,11E,13E)-henicosa-9,11,13-trienoyl]oxy-3-[(E)-tridec-8-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] (E)-icos-13-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-hexadecanoyloxy-2-[(E)-hexadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-2-[(E)-dodec-5-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[3-[(10E,13E,16E)-nonadeca-10,13,16-trienoyl]oxy-2-[(E)-pentadec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(E)-tetradec-9-enoyl]oxypropyl] henicosanoate

C40H78NO8P (731.5464757999999)

[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-7-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(5E,8E,11E)-icosa-5,8,11-trienoyl]oxy-3-[(E)-tetradec-9-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(E)-hexadec-7-enoyl]oxy-3-[(11E,13E,15E)-octadeca-11,13,15-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-2-[(E)-heptadec-9-enoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(11E,14E,17E,20E)-tricosa-11,14,17,20-tetraenoyl]oxy-3-undecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-7-enoyl]oxypropan-2-yl] nonadecanoate

C40H78NO8P (731.5464757999999)

[(2R)-2-[(E)-octadec-13-enoyl]oxy-3-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-9-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[(E)-octadec-6-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-2-octadecanoyloxy-3-[(E)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] (E)-octadec-13-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-13-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] (E)-octadec-4-enoate

C40H78NO8P (731.5464757999999)

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-heptadecanoyloxypropyl] octadec-17-enoate

C40H78NO8P (731.5464757999999)

4-[3-decanoyloxy-2-[(9E,12E,15E,18E)-tetracosa-9,12,15,18-tetraenoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-heptadec-9-enoyl]oxypropan-2-yl] octadecanoate

C40H78NO8P (731.5464757999999)

4-[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-octadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-3-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] (E)-tetracos-15-enoate

C40H78NO8P (731.5464757999999)

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-9-enoyl]oxypropan-2-yl] nonadecanoate

C40H78NO8P (731.5464757999999)

4-[3-[(E)-nonadec-9-enoyl]oxy-2-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-[(E)-octadec-7-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2S)-2-dodecanoyloxy-3-[(E)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[2-[(E)-dec-4-enoyl]oxy-3-[(15E,18E,21E)-tetracosa-15,18,21-trienoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-[(E)-octadec-4-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

[(2S)-2-decanoyloxy-3-[(E)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

4-[3-[(7E,10E,13E,16E)-nonadeca-7,10,13,16-tetraenoyl]oxy-2-pentadecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(13E,16E,19E)-docosa-13,16,19-trienoyl]oxy-3-[(E)-dodec-5-enoyl]oxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

4-[2-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-3-tridecanoyloxypropoxy]-2-(trimethylazaniumyl)butanoate

C44H77NO7 (731.5699732)

[(2R)-3-[(E)-octadec-11-enoyl]oxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C40H78NO8P (731.5464757999999)

2-[[(E)-2-[[(Z)-heptadec-9-enoyl]amino]-3,4-dihydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O7P+ (731.5702840000001)

2-[[(8E,12E)-2-(heptadecanoylamino)-3,4-dihydroxyoctadeca-8,12-dienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O7P+ (731.5702840000001)

2-[[2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3,4-dihydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C40H80N2O7P+ (731.5702840000001)

1-Oleoyl-2-myristoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-Palmitoyl-2-palmitoleoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are hexadecanoyl and (9Z)-hexadec-9-enoyl respectively.

1-Palmitoleoyl-2-palmitoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

A phosphatidylcholine 16:0_16:1 in which the acyl groups specified at positions 1 and 2 are palmitoleoyl and palmitoyl respectively.

1-(9Z-tetradecenoyl)-2-octadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

PC(18:0/14:1(9Z))

C40H78NO8P (731.5464757999999)

PC(18:1(11Z)/14:0)

C40H78NO8P (731.5464757999999)

1-tetradecanoyl-2-(11Z-octadecenoyl)-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

A phosphatidylcholine 32:1 in which the acyl groups at C-1 and C-2 are tetradecanoyl and (11Z)-octadec-11-enoyl respectively.

PE-NMe(16:0/18:1(9Z))

C40H78NO8P (731.5464757999999)

1-pentadecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-(11Z-eicosenoyl)-2-pentadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

PE-NMe(14:1(9Z)/20:0)

C40H78NO8P (731.5464757999999)

PE-NMe(16:1(9Z)/18:0)

C40H78NO8P (731.5464757999999)

PE-NMe(18:0/16:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe(20:0/14:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe(14:0/20:1(11Z))

C40H78NO8P (731.5464757999999)

PE-NMe(16:0/18:1(11Z))

C40H78NO8P (731.5464757999999)

PE-NMe(18:1(11Z)/16:0)

C40H78NO8P (731.5464757999999)

PE-NMe(20:1(11Z)/14:0)

C40H78NO8P (731.5464757999999)

PE-NMe2(15:0/18:1(9Z))

C40H78NO8P (731.5464757999999)

PE-NMe2(18:1(9Z)/15:0)

C40H78NO8P (731.5464757999999)

PE-NMe2(18:1(11Z)/15:0)

C40H78NO8P (731.5464757999999)

1-(9Z-heptadecenoyl)-2-octadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-octadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-dodecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-(9Z-tetradecenoyl)-2-heneicosanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-tridecanoyl-2-(11Z-docosenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-tridecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-(9Z-pentadecenoyl)-2-heptadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-heptadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-(9Z-heptadecenoyl)-2-pentadecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-(9Z-nonadecenoyl)-2-tridecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-pentadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-(11Z-eicosenoyl)-2-dodecanoyl-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

1-(9Z-octadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-N-methylethanolamine

C40H78NO8P (731.5464757999999)

1-(9Z-octadecenoyl)-2-heptadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-nonadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-eicosanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-(9Z-pentadecenoyl)-2-eicosanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-hexadecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-(9Z-hexadecenoyl)-2-nonadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-(9Z-nonadecenoyl)-2-hexadecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-heneicosanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-heptadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

1-(11Z-docosenoyl)-2-tridecanoyl-glycero-3-phosphoethanolamine

C40H78NO8P (731.5464757999999)

phosphatidylethanolamine 35:1

C40H78NO8P (731.5464757999999)

A phosphatidylethanolamine in which the two acyl groups contain a total of 35 carbons and 1 double bond.

phosphatidylcholine 32:1

C40H78NO8P (731.5464757999999)

A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 32 carbons in total with 1 double bond.

phosphatidylethanolamine (15:0/20:1)

C40H78NO8P (731.5464757999999)

A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 15 carbons and no double bonds while that at C-2 contains 20 carbons and 1 double bond.

phosphatidylethanolamine (16:0/19:1)

C40H78NO8P (731.5464757999999)

A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 16 carbons and no double bonds while that at C-2 contains 19 carbons and 1 double bond.

phosphatidylethanolamine (17:0/18:1)

C40H78NO8P (731.5464757999999)

A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 17 carbons and no double bonds while that at C-2 contains 18 carbons and 1 double bond.

phosphatidylethanolamine (17:1/18:0)

C40H78NO8P (731.5464757999999)

A phosphatidylethanolamine 35:1 in which the acyl group at C-1 contains 17 carbons and 1 double bond while that at C-2 contains 18 carbons and no double bonds.

phosphatidylcholine (16:0/16:1)

C40H78NO8P (731.5464757999999)

A phosphatidylcholine 32:1 in which the fatty acyl groups at positions 1 and 2 are specified as C16:0 and C16:1 respectively.

1-[(9Z)-octadecenoyl]-2-tetradecanoyl-sn-glycero-3-phosphocholine

C40H78NO8P (731.5464757999999)

A phosphatidylcholine 32:1 in which the acyl groups specified at positions 1 and 2 are oleoyl and myristoyl respectively.

PC(14:1(9Z)/18:0)

C40H78NO8P (731.5464757999999)

MePC(31:1)

C40H78NO8P (731.5464757999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

CerP(40:2)

C40H78NO8P (731.5464757999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

CerP(44:6)

C44H78NO5P (731.5617307999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

CerP(43:7)

C43H74NO6P (731.5253473999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(37:6)

C43H73NO8 (731.5335898)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(38:5)

C44H77NO7 (731.5699732)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

dMePE(33:1)

C40H78NO8P (731.5464757999999)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

Hex1Cer(34:1)

C40H77NO10 (731.5547182)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DGCC 30:0;O2

C40H77NO10 (731.5547182)

DGCC 33:5

C43H73NO8 (731.5335898)

DGTS 33:5;O

C43H73NO8 (731.5335898)

DGTS 34:4

C44H77NO7 (731.5699732)

MGCC 34:5

C44H77NO7 (731.5699732)

PE-NMe 16:0/18:1(9Z)

C40H78NO8P (731.5464757999999)

PC 10:0_22:1

C40H78NO8P (731.5464757999999)

PC 12:0_20:1

C40H78NO8P (731.5464757999999)

PC 12:0/20:1

C40H78NO8P (731.5464757999999)

PC 14:0_18:1

C40H78NO8P (731.5464757999999)

PC 14:0/18:1

C40H78NO8P (731.5464757999999)

PC 14:1_18:0

C40H78NO8P (731.5464757999999)

PC 14:1(9Z)/18:0

C40H78NO8P (731.5464757999999)

PC 15:0_17:1

C40H78NO8P (731.5464757999999)

PC 15:1_17:0

C40H78NO8P (731.5464757999999)

PC 16:0_16:1

C40H78NO8P (731.5464757999999)

PC 16:0/16:1

C40H78NO8P (731.5464757999999)

PC 16:0/16:1(7Z)

C40H78NO8P (731.5464757999999)

PC 16:1(7Z)/16:0

C40H78NO8P (731.5464757999999)

PC 18:0/14:1

C40H78NO8P (731.5464757999999)

PC 28:0/4:1

C40H78NO8P (731.5464757999999)

LNAPE 35:1

C40H78NO8P (731.5464757999999)

PE 11:0_24:1

C40H78NO8P (731.5464757999999)

PE 13:0_22:1

C40H78NO8P (731.5464757999999)

PE 14:1_21:0

C40H78NO8P (731.5464757999999)

PE 15:0_20:1

C40H78NO8P (731.5464757999999)

PE 15:1_20:0

C40H78NO8P (731.5464757999999)

PE 16:0_19:1

C40H78NO8P (731.5464757999999)

PE 16:1_19:0

C40H78NO8P (731.5464757999999)

PE 17:0_18:1

C40H78NO8P (731.5464757999999)

PE 17:0/18:1

C40H78NO8P (731.5464757999999)

PE 17:1_18:0

C40H78NO8P (731.5464757999999)

PE 31:0/4:1

C40H78NO8P (731.5464757999999)

CerP 21:1;O2/22:6

C43H74NO6P (731.5253473999999)

CerP 21:2;O2/22:5

C43H74NO6P (731.5253473999999)

CerP 43:7;O2

C43H74NO6P (731.5253473999999)

GalCer 15:0;O2/22:6

C43H73NO8 (731.5335898)

GalCer 15:1;O2/22:5

C43H73NO8 (731.5335898)

GalCer 15:2;O2/22:4

C43H73NO8 (731.5335898)

GalCer 17:1;O2/20:5

C43H73NO8 (731.5335898)

GalCer 17:2;O2/20:4

C43H73NO8 (731.5335898)

GalCer 19:2;O2/18:4

C43H73NO8 (731.5335898)

GalCer 37:6;O2

C43H73NO8 (731.5335898)

GlcCer 15:0;O2/22:6

C43H73NO8 (731.5335898)

GlcCer 15:1;O2/22:5

C43H73NO8 (731.5335898)

GlcCer 15:2;O2/22:4

C43H73NO8 (731.5335898)

GlcCer 17:1;O2/20:5

C43H73NO8 (731.5335898)

GlcCer 17:2;O2/20:4

C43H73NO8 (731.5335898)

GlcCer 19:2;O2/18:4

C43H73NO8 (731.5335898)

GlcCer 37:6;O2

C43H73NO8 (731.5335898)

HexCer 15:0;O2/22:6

C43H73NO8 (731.5335898)

HexCer 15:1;O2/22:5

C43H73NO8 (731.5335898)

HexCer 15:2;O2/22:4

C43H73NO8 (731.5335898)

HexCer 17:1;O2/20:5

C43H73NO8 (731.5335898)

HexCer 17:2;O2/20:4

C43H73NO8 (731.5335898)

HexCer 19:2;O2/18:4

C43H73NO8 (731.5335898)

HexCer 37:6;O2

C43H73NO8 (731.5335898)